UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:EPHA4-COL4A3 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: EPHA4-COL4A3 | FusionPDB ID: 26960 | FusionGDB2.0 ID: 26960 | Hgene | Tgene | Gene symbol | EPHA4 | COL4A3 | Gene ID | 2043 | 1285 |
Gene name | EPH receptor A4 | collagen type IV alpha 3 chain | |
Synonyms | EK8|HEK8|SEK|TYRO1 | ATS2|ATS3 | |
Cytomap | 2q36.1 | 2q36.3 | |
Type of gene | protein-coding | protein-coding | |
Description | ephrin type-A receptor 4EPH-like kinase 8TYRO1 protein tyrosine kinasereceptor protein-tyrosine kinase HEK8tyrosine-protein kinase TYRO1tyrosine-protein kinase receptor SEK | collagen alpha-3(IV) chaincollagen IV, alpha-3 polypeptidecollagen, type IV, alpha 3 (Goodpasture antigen)tumstatin | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P54764 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000281821, ENST00000392071, ENST00000409854, ENST00000409938, ENST00000469354, | ENST00000468753, ENST00000396578, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 3 X 3=36 | 3 X 4 X 2=24 |
# samples | 4 | 4 | |
** MAII score | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: EPHA4 [Title/Abstract] AND COL4A3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | EPHA4(222428451)-COL4A3(228102684), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. EPHA4-COL4A3 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EPHA4 | GO:0018108 | peptidyl-tyrosine phosphorylation | 12775584 |
Hgene | EPHA4 | GO:0046777 | protein autophosphorylation | 12775584 |
Hgene | EPHA4 | GO:2001108 | positive regulation of Rho guanyl-nucleotide exchange factor activity | 12775584 |
Tgene | COL4A3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 10766752 |
Tgene | COL4A3 | GO:0016525 | negative regulation of angiogenesis | 10766752|12682293 |
Tgene | COL4A3 | GO:0072577 | endothelial cell apoptotic process | 10766752 |
Tgene | COL4A3 | GO:1905563 | negative regulation of vascular endothelial cell proliferation | 10766752 |
Fusion gene breakpoints across EPHA4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across COL4A3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-34-5236-01A | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000281821 | EPHA4 | chr2 | 222428451 | - | ENST00000396578 | COL4A3 | chr2 | 228102684 | + | 8713 | 865 | 601 | 5790 | 1729 |
ENST00000409854 | EPHA4 | chr2 | 222428451 | - | ENST00000396578 | COL4A3 | chr2 | 228102684 | + | 8706 | 858 | 594 | 5783 | 1729 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000281821 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + | 0.001288369 | 0.9987116 |
ENST00000409854 | ENST00000396578 | EPHA4 | chr2 | 222428451 | - | COL4A3 | chr2 | 228102684 | + | 0.001275697 | 0.9987243 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >26960_26960_1_EPHA4-COL4A3_EPHA4_chr2_222428451_ENST00000281821_COL4A3_chr2_228102684_ENST00000396578_length(amino acids)=1729AA_BP=1161 MWGPASPWYQSVCSIKSVHSQSAIWPSFLTPSQGLIRLPWWKFEAPVSTTQKRKMCQKCTVGQMVNGWYPLATAYATLGMRSGAENAKGC VCKDKGQCFCDGAKGEKGEKGFPGPPGSPGQKGFTGPEGLPGPQGPKGFPGLPGLTGSKGVRGISGLPGFSGSPGLPGTPGNTGPYGLVG VPGCSGSKGEQGFPGLPGTLGYPGIPGAAGLKGQKGAPAKEEDIELDAKGDPGLPGAPGPQGLPGPPGFPGPVGPPGPPGFFGFPGAMGP RGPKGHMGERVIGHKGERGVKGLTGPPGPPGTVIVTLTGPDNRTDLKGEKGDKGAMGEPGPPGPSGLPGESYGSEKGAPGDPGLQGKPGK DGVPGFPGSEGVKGNRGFPGLMGEDGIKGQKGDIGPPGFRGPTEYYDTYQEKGDEGTPGPPGPRGARGPQGPSGPPGVPGSPGSSRPGLR GAPGWPGLKGSKGERGRPGKDAMGTPGSPGCAGSPGLPGSPGPPGPPGDIVFRKGPPGDHGLPGYLGSPGIPGVDGPKGEPGLLCTQCPY IPGPPGLPGLPGLHGVKGIPGRQGAAGLKGSPGSPGNTGLPGFPGFPGAQGDPGLKGEKGETLQPEGQVGVPGDPGLRGQPGRKGLDGIP GTPGVKGLPGPKGELALSGEKGDQGPPGDPGSPGSPGPAGPAGPPGYGPQGEPGLQGTQGVPGAPGPPGEAGPRGELSVSTPVPGPPGPP GPPGHPGPQGPPGIPGSLGKCGDPGLPGPDGEPGIPGIGFPGPPGPKGDQGFPGTKGSLGCPGKMGEPGLPGKPGLPGAKGEPAVAMPGG PGTPGFPGERGNSGEHGEIGLPGLPGLPGTPGNEGLDGPRGDPGQPGPPGEQGPPGRCIEGPRGAQGLPGLNGLKGQQGRRGKTGPKGDP GIPGLDRSGFPGETGSPGIPGHQGEMGPLGQRGYPGNPGILGPPGEDGVIGMMGFPGAIGPPGPPGNPGTPGQRGSPGIPGVKGQRGTPG AKGEQGDKGNPGPSEISHVIGDKGEPGLKGFAGNPGEKGNRGVPGMPGLKGLKGLPGPAGPPGPRGDLGSTGNPGEPGLRGIPGSMGNMG MPGSKGKRGTLGFPGRAGRPGLPGIHGLQGDKGEPGYSEGTRPGPPGPTGDPGLPGDMGKKGEMGQPGPPGHLGPAGPEGAPGSPGSPGL PGKPGPHGDLGFKGIKGLLGPPGIRGPPGLPGFPGSPGPMGIRGDQGRDGIPGPAGEKGETGLLRAPPGPRGNPGAQGAKGDRGAPGFPG LPGRKGAMGDAGPRGPTGIEGFPGPPGLPGAIIPGQTGNRGPPGSRGSPGAPGPPGPPGSHVIGIKGDKGSMGHPGPKGPPGTAGDMGPP GRLGAPGTPGLPGPRGDPGFQGFPGVKGEKGNPGFLGSIGPPGPIGPKGPPGVRGDPGTLKIISLPGSPGPPGTPGEPGMQGEPGPPGPP GNLGPCGPRGKPGKDGKPGTPGPAGEKGNKGSKGEPGPAGSDGLPGLKGKRGDSGSPATWTTRGFVFTRHSQTTAIPSCPEGTVPLYSGF SFLFVQGNQRAHGQDLGTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVH SQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVK -------------------------------------------------------------- >26960_26960_2_EPHA4-COL4A3_EPHA4_chr2_222428451_ENST00000409854_COL4A3_chr2_228102684_ENST00000396578_length(amino acids)=1729AA_BP=1161 MWGPASPWYQSVCSIKSVHSQSAIWPSFLTPSQGLIRLPWWKFEAPVSTTQKRKMCQKCTVGQMVNGWYPLATAYATLGMRSGAENAKGC VCKDKGQCFCDGAKGEKGEKGFPGPPGSPGQKGFTGPEGLPGPQGPKGFPGLPGLTGSKGVRGISGLPGFSGSPGLPGTPGNTGPYGLVG VPGCSGSKGEQGFPGLPGTLGYPGIPGAAGLKGQKGAPAKEEDIELDAKGDPGLPGAPGPQGLPGPPGFPGPVGPPGPPGFFGFPGAMGP RGPKGHMGERVIGHKGERGVKGLTGPPGPPGTVIVTLTGPDNRTDLKGEKGDKGAMGEPGPPGPSGLPGESYGSEKGAPGDPGLQGKPGK DGVPGFPGSEGVKGNRGFPGLMGEDGIKGQKGDIGPPGFRGPTEYYDTYQEKGDEGTPGPPGPRGARGPQGPSGPPGVPGSPGSSRPGLR GAPGWPGLKGSKGERGRPGKDAMGTPGSPGCAGSPGLPGSPGPPGPPGDIVFRKGPPGDHGLPGYLGSPGIPGVDGPKGEPGLLCTQCPY IPGPPGLPGLPGLHGVKGIPGRQGAAGLKGSPGSPGNTGLPGFPGFPGAQGDPGLKGEKGETLQPEGQVGVPGDPGLRGQPGRKGLDGIP GTPGVKGLPGPKGELALSGEKGDQGPPGDPGSPGSPGPAGPAGPPGYGPQGEPGLQGTQGVPGAPGPPGEAGPRGELSVSTPVPGPPGPP GPPGHPGPQGPPGIPGSLGKCGDPGLPGPDGEPGIPGIGFPGPPGPKGDQGFPGTKGSLGCPGKMGEPGLPGKPGLPGAKGEPAVAMPGG PGTPGFPGERGNSGEHGEIGLPGLPGLPGTPGNEGLDGPRGDPGQPGPPGEQGPPGRCIEGPRGAQGLPGLNGLKGQQGRRGKTGPKGDP GIPGLDRSGFPGETGSPGIPGHQGEMGPLGQRGYPGNPGILGPPGEDGVIGMMGFPGAIGPPGPPGNPGTPGQRGSPGIPGVKGQRGTPG AKGEQGDKGNPGPSEISHVIGDKGEPGLKGFAGNPGEKGNRGVPGMPGLKGLKGLPGPAGPPGPRGDLGSTGNPGEPGLRGIPGSMGNMG MPGSKGKRGTLGFPGRAGRPGLPGIHGLQGDKGEPGYSEGTRPGPPGPTGDPGLPGDMGKKGEMGQPGPPGHLGPAGPEGAPGSPGSPGL PGKPGPHGDLGFKGIKGLLGPPGIRGPPGLPGFPGSPGPMGIRGDQGRDGIPGPAGEKGETGLLRAPPGPRGNPGAQGAKGDRGAPGFPG LPGRKGAMGDAGPRGPTGIEGFPGPPGLPGAIIPGQTGNRGPPGSRGSPGAPGPPGPPGSHVIGIKGDKGSMGHPGPKGPPGTAGDMGPP GRLGAPGTPGLPGPRGDPGFQGFPGVKGEKGNPGFLGSIGPPGPIGPKGPPGVRGDPGTLKIISLPGSPGPPGTPGEPGMQGEPGPPGPP GNLGPCGPRGKPGKDGKPGTPGPAGEKGNKGSKGEPGPAGSDGLPGLKGKRGDSGSPATWTTRGFVFTRHSQTTAIPSCPEGTVPLYSGF SFLFVQGNQRAHGQDLGTLGSCLQRFTTMPFLFCNVNDVCNFASRNDYSYWLSTPALMPMNMAPITGRALEPYISRCTVCEGPAIAIAVH SQTTDIPPCPHGWISLWKGFSFIMFTSAGSEGTGQALASPGSCLEEFRASPFLECHGRGTCNYYSNSYSFWLASLNPERMFRKPIPSTVK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:222428451/chr2:228102684) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
EPHA4 | . |
FUNCTION: Receptor tyrosine kinase which binds membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous, it has the unique property among Eph receptors to bind and to be physiologically activated by both GPI-anchored ephrin-A and transmembrane ephrin-B ligands including EFNA1 and EFNB3. Upon activation by ephrin ligands, modulates cell morphology and integrin-dependent cell adhesion through regulation of the Rac, Rap and Rho GTPases activity. Plays an important role in the development of the nervous system controlling different steps of axonal guidance including the establishment of the corticospinal projections. May also control the segregation of motor and sensory axons during neuromuscular circuit development. In addition to its role in axonal guidance plays a role in synaptic plasticity. Activated by EFNA1 phosphorylates CDK5 at 'Tyr-15' which in turn phosphorylates NGEF regulating RHOA and dendritic spine morphogenesis. In the nervous system, plays also a role in repair after injury preventing axonal regeneration and in angiogenesis playing a role in central nervous system vascular formation. Additionally, its promiscuity makes it available to participate in a variety of cell-cell signaling regulating for instance the development of the thymic epithelium. During development of the cochlear organ of Corti, regulates pillar cell separation by forming a ternary complex with ADAM10 and CADH1 which facilitates the cleavage of CADH1 by ADAM10 and disruption of adherens junctions (By similarity). {ECO:0000250|UniProtKB:Q03137, ECO:0000269|PubMed:17143272}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 30_209 | 274.3333333333333 | 2072.6666666666665 | Domain | Eph LBD |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 30_209 | 274.3333333333333 | 987.0 | Domain | Eph LBD |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1445_1669 | 29.0 | 1671.0 | Domain | Collagen IV NC1 | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1154_1156 | 29.0 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1306_1308 | 29.0 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1345_1347 | 29.0 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1432_1434 | 29.0 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 791_793 | 29.0 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 996_998 | 29.0 | 1671.0 | Motif | Cell attachment site | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1427_1444 | 29.0 | 1671.0 | Region | Note=Epitope recognized by Goodpasture antibodies | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1479_1557 | 29.0 | 1671.0 | Region | Note=Required for the anti-angiogenic activity of tumstatin | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 1610_1628 | 29.0 | 1671.0 | Region | Note=Required for the anti-tumor cell activity of tumstatin | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 29_42 | 29.0 | 1671.0 | Region | Note=7S domain | |
Tgene | COL4A3 | chr2:222428451 | chr2:228102684 | ENST00000396578 | 0 | 52 | 43_1438 | 29.0 | 1671.0 | Region | Note=Triple-helical region |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 191_325 | 274.3333333333333 | 2072.6666666666665 | Compositional bias | Note=Cys-rich |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 191_325 | 274.3333333333333 | 987.0 | Compositional bias | Note=Cys-rich |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 328_439 | 274.3333333333333 | 2072.6666666666665 | Domain | Fibronectin type-III 1 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 440_537 | 274.3333333333333 | 2072.6666666666665 | Domain | Fibronectin type-III 2 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 621_882 | 274.3333333333333 | 2072.6666666666665 | Domain | Protein kinase |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 911_975 | 274.3333333333333 | 2072.6666666666665 | Domain | SAM |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 328_439 | 274.3333333333333 | 987.0 | Domain | Fibronectin type-III 1 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 440_537 | 274.3333333333333 | 987.0 | Domain | Fibronectin type-III 2 |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 621_882 | 274.3333333333333 | 987.0 | Domain | Protein kinase |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 911_975 | 274.3333333333333 | 987.0 | Domain | SAM |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 984_986 | 274.3333333333333 | 2072.6666666666665 | Motif | PDZ-binding |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 984_986 | 274.3333333333333 | 987.0 | Motif | PDZ-binding |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 627_635 | 274.3333333333333 | 2072.6666666666665 | Nucleotide binding | ATP |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 627_635 | 274.3333333333333 | 987.0 | Nucleotide binding | ATP |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 20_547 | 274.3333333333333 | 2072.6666666666665 | Topological domain | Extracellular |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 570_986 | 274.3333333333333 | 2072.6666666666665 | Topological domain | Cytoplasmic |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 20_547 | 274.3333333333333 | 987.0 | Topological domain | Extracellular |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 570_986 | 274.3333333333333 | 987.0 | Topological domain | Cytoplasmic |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000281821 | - | 3 | 18 | 548_569 | 274.3333333333333 | 2072.6666666666665 | Transmembrane | Helical |
Hgene | EPHA4 | chr2:222428451 | chr2:228102684 | ENST00000409938 | - | 4 | 18 | 548_569 | 274.3333333333333 | 987.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
EPHA4 | |
COL4A3 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to EPHA4-COL4A3 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to EPHA4-COL4A3 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |